Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses
I Benotmane, G Gautier, P Perrin, J Olagne, N Cognard… - Jama, 2021 - jamanetwork.com
Methods| All kidney transplant recipients followed up in the outpatient Kidney Transplantation
Department of Strasbourg University Hospital between January 20, 2021, and June 3, …
Department of Strasbourg University Hospital between January 20, 2021, and June 3, …
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine
…, G Gautier-Vargas, N Cognard, J Olagne… - Kidney …, 2021 - kidney-international.org
2 (SARS-CoV-2) have not been specifically investigated in kidney transplant recipient (KTRs).
Preliminary results suggest that among KTRs who received the first injection of an mRNA-…
Preliminary results suggest that among KTRs who received the first injection of an mRNA-…
Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
…, G Gautier-Vargas, N Cognard, J Olagne… - Kidney …, 2021 - kidney-international.org
To the editor: Several of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccines use a nucleosidemodified, purified mRNA lipid nanoparticle-encapsulated …
vaccines use a nucleosidemodified, purified mRNA lipid nanoparticle-encapsulated …
Risk factors for BK virus infection in the era of therapeutic drug monitoring
C Borni-Duval, S Caillard, J Olagne, P Perrin… - …, 2013 - journals.lww.com
Background Overimmunosuppression is a widely recognized risk factor for BK virus (BKV)
infection, particularly with the combination of tacrolimus, mycophenolate mofetil (MMF), and …
infection, particularly with the combination of tacrolimus, mycophenolate mofetil (MMF), and …
Breakthrough COVID‐19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients
…, A Velay, G Gautier‐Vargas, J Olagne… - American Journal of …, 2022 - Wiley Online Library
The cilgavimab−tixagevimab combination retains a partial in vitro neutralizing activity against
the current SARS‐CoV‐2 variants of concern (omicron BA.1, BA.1.1, and BA.2). Here, we …
the current SARS‐CoV‐2 variants of concern (omicron BA.1, BA.1.1, and BA.2). Here, we …
Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant
…, A Velay, G Gautier-Vargas, J Olagne… - Kidney …, 2022 - kidney-international.org
To the editor: Immunocompromised patients show an impaired vaccine-induced immune
response, resulting in an increased risk of severe coronavirus disease 2019 (COVID-19). 1 In …
response, resulting in an increased risk of severe coronavirus disease 2019 (COVID-19). 1 In …
B7–1 blockade does not improve post–transplant nephrotic syndrome caused by recurrent FSGS
…, V Audard, T Kofman, L Braun, J Olagne… - Journal of the …, 2016 - journals.lww.com
FSGS is a common glomerular disorder that has a high propensity for recurrence after kidney
transplant. The pathophysiology of FSGS is unknown, but podocytes seem to be the target …
transplant. The pathophysiology of FSGS is unknown, but podocytes seem to be the target …
In‐depth virological assessment of kidney transplant recipients with COVID‐19
…, M Solis, F Gallais, N Cognard, J Olagne… - American Journal of …, 2020 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has spread widely, causing
coronavirus disease 2019 (COVID‐19) and significant mortality. However, data on viral …
coronavirus disease 2019 (COVID‐19) and significant mortality. However, data on viral …
Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV‐associated nephropathy in kidney transplant recipients—results from a proof …
…, M Solis, A Velay, N Cognard, J Olagne… - American Journal of …, 2021 - Wiley Online Library
BK virus (BKV) replication occurs frequently in kidney transplant recipients (KTR), potentially
leading to BKV‐associated nephropathy (BKVAN) and graft loss. Patients with high titers of …
leading to BKV‐associated nephropathy (BKVAN) and graft loss. Patients with high titers of …
[HTML][HTML] Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19
…, P Gantner, N Cognard, J Olagne… - American Journal of …, 2021 - ncbi.nlm.nih.gov
A recent study demonstrated that a single dose of a severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) mRNA-based vaccine is sufficient to mount a robust immunological …
coronavirus 2 (SARS-CoV-2) mRNA-based vaccine is sufficient to mount a robust immunological …